Get started
Work

Supplementary Table 2 from HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

Year: 2023
Type: supplementary-materials
Abstract: Supplementary Table 2. Probe sets showing 2-fold difference in expression in 2 independent experiments with romidepsin treatment of LKR. Probe sets with very low expression (cutoff of <100 under all tested conditions) were removed. Probe set ID, direction of change after romidepsin treatment, accession number and gene symbol when available are indicated.
DOI: 10.1158/1078-0432.22454714.v1
Authors: Hong Zheng, Weipeng Zhao, Cihui Yan, Crystina C. Watson, Michael Massengill, Mengyu Xie, Chris Massengill, David R. Noyes, Gary V. Martinez, Roha Afzal, Zhihua Chen, Xiubao Ren, Scott J. Antonia, Eric B. Haura, Brian Ruffell, Amer A. Beg
Language: English
Open Access status: gold
OpenAlex ID: W4361909472
Cites:
Cited by:
Related to: 10